Literature DB >> 17868211

Management of chronic hand eczema.

Thomas L Diepgen1, Tove Agner, Werner Aberer, John Berth-Jones, Frédéric Cambazard, Peter Elsner, John McFadden, Pieter Jan Coenraads.   

Abstract

Hand eczema (HE) is one of the most frequent skin diseases and has often a chronically relapsing course with a poor prognosis resulting in a high social and economic impact for the individual and the society. In this article, we highlight the results of an expert workshop on the 'management of severe chronic hand eczema' with the focus on the epidemiology, the burden of severe HE, its classification and diagnostic procedures, and the current status of treatment options according to an evidence-based approach (randomized controlled clinical trials, RCTs). We conclude that despite the abundance of topical and systemic treatment options, disease management in patients with severe chronic HE is frequently inadequate. There is a strong need for RCTs of existing and new treatment options based on clearly diagnosed subtypes of HE and its severity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868211     DOI: 10.1111/j.1600-0536.2007.01179.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  36 in total

Review 1.  Alitretinoin: A Review in Severe Chronic Hand Eczema.

Authors:  Hannah A Blair; Lesley J Scott
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

Review 2.  [Hand eczema registries: Background, value and future prospects : Registry data in hand eczema research].

Authors:  Robert Ofenloch; Christian Apfelbacher; Elke Weisshaar
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

3.  Development and validation of a questionnaire on 'Satisfaction with dermatological treatment of hand eczema' (DermaSat).

Authors:  Miguel A Ruiz; Felipe Heras; Agusti Alomar; Luis Conde-Salazar; Jesús de la Cuadra; Esther Serra; Francisco Regalado; Ralf Halbach
Journal:  Health Qual Life Outcomes       Date:  2010-11-05       Impact factor: 3.186

4.  The Hand Eczema Trial (HET): Design of a randomised clinical trial of the effect of classification and individual counselling versus no intervention among health-care workers with hand eczema.

Authors:  Kristina Sophie Ibler; Tove Agner; Jane Lindschou Hansen; Christian Gluud
Journal:  BMC Dermatol       Date:  2010-08-31

5.  Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema--a long-term analysis from a Swiss perspective.

Authors:  Patricia R Blank; Armin A Blank; Thomas D Szucs
Journal:  BMC Dermatol       Date:  2010-06-25

Review 6.  [Chronic hand eczema: epidemiology and therapeutic evidence].

Authors:  T L Diepgen
Journal:  Hautarzt       Date:  2008-09       Impact factor: 0.751

Review 7.  [New and rarley used treatment options for refractory hand eczema: local UVA-1 phototherapy, retinoids, calcineurin inhibitors].

Authors:  U Raap; C Kenneweg; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2008-09       Impact factor: 0.751

Review 8.  [Alitretinoin: a new treatment option for chronic refractory hand eczema].

Authors:  S Molin; T Ruzicka
Journal:  Hautarzt       Date:  2008-09       Impact factor: 0.751

Review 9.  Alitretinoin: in severe chronic hand eczema.

Authors:  Karly P Garnock-Jones; Caroline M Perry
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

10.  Alitretinoin--its use in intractable hand eczema and other potential indications.

Authors:  Bibi Petersen; Gregor B E Jemec
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.